The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology
Open accessAbstract
Prevalence is the best indicator of cancer survivorship in the population, but few studies have focused on brain tumor prevalence because of previous data limitations. Hence, the full impact of primary brain tumors on the healthcare system in the United States is not completely described. The present study provides an estimate of the prevalence of disease in the United States, updating an earlier prevalence study. Incidence data for 2004 and survival data for 1985-2005 were obtained by the Central Brain Tumor Registry of the United States from selected regions, modeled under 2 different survival assumptions, to estimate prevalence rates for the year 2004 and projected estimates for 2010. The overall incidence rate for primary brain tumors was 18.1 per 100 000 person-years with 2-, 5-, 10-, and 20-year observed survival rates of 62%, 54%, 45%, and 30%, respectively. On the basis of the sum of nonmalignant and averaged malignant estimates, the overall prevalence rate of individuals with a brain tumor was estimated to be 209.0 per 100 000 in 2004 and 221.8 per 100 000 in 2010. The female prevalence rate (264.8 per 100 000) was higher than that in males (158.7 per 100 000). The averaged prevalence rate for malignant tumors (42.5 per 100 000) was lower than the prevalence for nonmalignant tumors (166.5 per 100 000). This study provides estimates of the 2004 (n = 612 770) and 2010 (n = 688 096) expected number of individuals living with primary brain tumor diagnoses in the United States, providing more current and robust estimates for aiding healthcare planning and patient advocacy for an aging US population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Fisher, J. L., Schwartzbaum, J. A., Wrensch, M., & Wiemels, J. L. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.07.002 · Cited by 528
United States Life Tables, 2021
Arias, E., Xu, J., & Kochanek, K. (2023) · doi:10.15620/cdc:132418 · Cited by 379
Deorah, S., Lynch, C. F., Sibenaller, Z. A., & Ryken, T. C. (2006) · Neurosurgical Focus · doi:10.3171/foc.2006.20.4.e1 · Cited by 347
Claus, E. B., & Black, P. M. (2006) · Cancer · doi:10.1002/cncr.21733 · Cited by 226
Feldman, A. R., Kessler, L., Myers, M. H., & Naughton, M. D. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611273152206 · Cited by 207
Davis, F. G., Kupelian, V. A., Freels, S. A., McCarthy, B. J., & Surawicz, T. S. (2001) · Neuro-Oncology · doi:10.1093/neuonc/3.3.152 · Cited by 204
Self-citationMerrill, R. M., Capocaccia, R., Feuer, E. J., & Mariotto, A. B. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.2.197 · Cited by 118
Cited by
Glioblastoma and Other Malignant Gliomas: A Clinical Review
Omuro, A. (2013) · JAMA · doi:10.1001/jama.2013.280319 · Cited by 2,301
Wainwright, D. A., Chang, A. L., Dey, M., Balyasnikova, I. V., Kim, C. K., Tobias, A., Cheng, Y., Kim, J. W., Qiao, J., Zhang, L., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0514 · Cited by 576
Emerging insights into the molecular and cellular basis of glioblastoma
Dunn, G. P., Rinne, M. L., Wykosky, J., Genovese, G., Quayle, S. N., Dunn, I. F., Agarwalla, P. K., Chheda, M. G., Campos, B., Wang, A., et al. (2012) · Genes & Development · doi:10.1101/gad.187922.112 · Cited by 565
The integrated landscape of driver genomic alterations in glioblastoma
Frattini, V., Trifonov, V., Chan, J. M., Castano, A., Lia, M., Abate, F., Keir, S. T., Ji, A. X., Zoppoli, P., Niola, F., et al. (2013) · Nature Genetics · doi:10.1038/ng.2734 · Cited by 524
de Robles, P., Fiest, K. M., Frolkis, A. D., Pringsheim, T., Atta, C., St. Germaine-Smith, C., Day, L., Lam, D., & Jette, N. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou283 · Cited by 338
Metadata
- Authors
- Porter, K. R., McCarthy, B. J., Freels, S., Kim, Y., & Davis, F. G.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-02-08
- Volume
- 12
- Issue
- 6
- Pages
- 520-527
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W2099337868
- Cited by
- 342
- References
- 14
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. https://app.cochat.ai/papers/10.1093/neuonc/nop066
- The paper
- Porter, K. R., McCarthy, B. J., Freels, S., Kim, Y., & Davis, F. G. (2010). Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro-Oncology. https://doi.org/10.1093/neuonc/nop066
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.